|
CA2213638C
(en)
*
|
1995-02-24 |
2004-05-04 |
Nanosystems L.L.C. |
Aerosols containing nanoparticle dispersions
|
|
UA72189C2
(uk)
|
1997-11-17 |
2005-02-15 |
Янссен Фармацевтика Н.В. |
Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
|
|
US20080102121A1
(en)
*
|
1998-11-02 |
2008-05-01 |
Elan Pharma International Limited |
Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone
|
|
US7521068B2
(en)
*
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
|
US6375986B1
(en)
|
2000-09-21 |
2002-04-23 |
Elan Pharma International Ltd. |
Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate
|
|
US6969529B2
(en)
|
2000-09-21 |
2005-11-29 |
Elan Pharma International Ltd. |
Nanoparticulate compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers
|
|
US20020061281A1
(en)
*
|
1999-07-06 |
2002-05-23 |
Osbakken Robert S. |
Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
|
|
US6576224B1
(en)
*
|
1999-07-06 |
2003-06-10 |
Sinuspharma, Inc. |
Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
|
|
AU3400501A
(en)
*
|
2000-02-28 |
2001-09-12 |
Vectura Ltd |
Improvements in or relating to the delivery of oral drugs
|
|
GB0009773D0
(en)
*
|
2000-04-19 |
2000-06-07 |
Univ Cardiff |
Particulate composition
|
|
US8512718B2
(en)
|
2000-07-03 |
2013-08-20 |
Foamix Ltd. |
Pharmaceutical composition for topical application
|
|
DE10043509A1
(de)
*
|
2000-09-01 |
2002-03-14 |
Asta Medica Ag |
Feste Peptidzubereitungen für die Inhalation und deren Herstellung
|
|
US6613308B2
(en)
*
|
2000-09-19 |
2003-09-02 |
Advanced Inhalation Research, Inc. |
Pulmonary delivery in treating disorders of the central nervous system
|
|
US7198795B2
(en)
*
|
2000-09-21 |
2007-04-03 |
Elan Pharma International Ltd. |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
|
|
US7998507B2
(en)
|
2000-09-21 |
2011-08-16 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors
|
|
DE10058772A1
(de)
*
|
2000-11-27 |
2002-06-06 |
Falk Pharma Gmbh |
Verfahren zur Herstellung leicht löslicher Arzneimittelformulierungen und entsprechende Formulierungen
|
|
EP1337240B2
(en)
*
|
2000-11-30 |
2014-09-24 |
Vectura Limited |
Method of making particles for use in a pharmaceutical composition
|
|
EP2298285A3
(en)
|
2000-11-30 |
2011-07-27 |
Vectura Limited |
Method of making particles for use in a pharmaceutical composition
|
|
EP1337239B2
(en)
*
|
2000-11-30 |
2015-11-25 |
Vectura Limited |
Particles for use in a pharmaceutical composition
|
|
AU2002215114A1
(en)
*
|
2000-11-30 |
2002-06-11 |
Vectura Limited |
Pharmaceutical compositions for inhalation
|
|
US8067032B2
(en)
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
|
US9700866B2
(en)
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
|
US6951656B2
(en)
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
|
US6977085B2
(en)
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
|
US7193084B2
(en)
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
|
US6884436B2
(en)
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
|
US7037528B2
(en)
|
2000-12-22 |
2006-05-02 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
|
GB0107106D0
(en)
*
|
2001-03-21 |
2001-05-09 |
Boehringer Ingelheim Pharma |
Powder inhaler formulations
|
|
RO121172B1
(ro)
*
|
2001-03-30 |
2007-01-30 |
Jago Research Ag |
Compoziţie farmaceutică de aerosol şi utilizarea acesteia
|
|
WO2002094242A1
(en)
|
2001-05-24 |
2002-11-28 |
Alexza Molecular Delivery Corporation |
Delivery of rizatriptan or zolmitriptan through an inhalation route
|
|
US20070122353A1
(en)
|
2001-05-24 |
2007-05-31 |
Hale Ron L |
Drug condensation aerosols and kits
|
|
US6805853B2
(en)
|
2001-11-09 |
2004-10-19 |
Alexza Molecular Delivery Corporation |
Delivery of diazepam through an inhalation route
|
|
US7090830B2
(en)
|
2001-05-24 |
2006-08-15 |
Alexza Pharmaceuticals, Inc. |
Drug condensation aerosols and kits
|
|
WO2002094229A1
(en)
*
|
2001-05-24 |
2002-11-28 |
Alexza Molecular Delivery Corporation |
Delivery of muscle relaxants through an inhalation route
|
|
WO2002094218A2
(en)
|
2001-05-24 |
2002-11-28 |
Alexza Molecular Delivery Corporation |
Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route
|
|
US7585493B2
(en)
|
2001-05-24 |
2009-09-08 |
Alexza Pharmaceuticals, Inc. |
Thin-film drug delivery article and method of use
|
|
US7458374B2
(en)
|
2002-05-13 |
2008-12-02 |
Alexza Pharmaceuticals, Inc. |
Method and apparatus for vaporizing a compound
|
|
US7498019B2
(en)
|
2001-05-24 |
2009-03-03 |
Alexza Pharmaceuticals, Inc. |
Delivery of compounds for the treatment of headache through an inhalation route
|
|
WO2002094246A2
(en)
*
|
2001-05-24 |
2002-11-28 |
Alexza Molecular Delivery Corporation |
Delivery of nonsteroidal antiinflammatory drugs through an inhalation route
|
|
US20030051728A1
(en)
|
2001-06-05 |
2003-03-20 |
Lloyd Peter M. |
Method and device for delivering a physiologically active compound
|
|
CA2446904A1
(en)
|
2001-05-24 |
2003-04-03 |
Alexza Molecular Delivery Corporation |
Delivery of drug esters through an inhalation route
|
|
JP4464129B2
(ja)
*
|
2001-09-19 |
2010-05-19 |
エラン ファーマ インターナショナル，リミティド |
ナノ粒子インスリン製剤
|
|
US20060003012A9
(en)
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
|
CN1558755A
(zh)
|
2001-09-26 |
2004-12-29 |
���ع��ʹ�˾ |
通过分散和除去溶剂或液相制备亚微米大小的纳米颗粒
|
|
US7112340B2
(en)
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
|
JP2005511629A
(ja)
*
|
2001-11-20 |
2005-04-28 |
アドバンスト インハレーション リサーチ，インコーポレイテッド |
持続作用生成物送達用組成物
|
|
CA2460343A1
(en)
|
2001-11-21 |
2003-07-17 |
Alexza Molecular Delivery Corporation |
Delivery of caffeine through an inhalation route
|
|
US20030129242A1
(en)
*
|
2002-01-04 |
2003-07-10 |
Bosch H. William |
Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer
|
|
PT3494995T
(pt)
|
2002-03-01 |
2020-03-30 |
Chiesi Farm Spa |
Formulação superfina de formoterol
|
|
EP1490030B2
(en)
*
|
2002-03-20 |
2010-07-14 |
Elan Pharma International Limited |
Nanoparticulate compositions of angiogenesis inhibitors
|
|
US20030185762A1
(en)
*
|
2002-03-22 |
2003-10-02 |
Cowan Siu Man L. |
Highly aqueous liquid carrier formulations
|
|
GB0219815D0
(en)
*
|
2002-08-24 |
2002-10-02 |
Accentus Plc |
Preparation of small crystals
|
|
FI20020857A7
(fi)
*
|
2002-05-07 |
2003-11-08 |
Focus Inhalation Oy |
Amorfisen aineen muuntaminen vastaavaksi kiteiseksi aineeksi spraykuivaamalla ja käyttämällä kiteistä spraykuivattua ainetta lääkevalmisteissa
|
|
BR0311883A
(pt)
*
|
2002-06-17 |
2005-04-05 |
Epigenesis Pharmaceuticals Llc |
Recipiente selado, kit, e, métodos para a profilaxia ou tratamento da asma, para a profilaxia ou tratamento da doença pulmonar obstrutiva crÈnica, para a redução ou exaustão da adenosina em um tecido do paciente e para profilaxia ou tratamento de um distúrbio ou condição associada com nìveis altos de adenosina ou sensibilidade à adenosina em um tecido do paciente
|
|
AU2003261167A1
(en)
*
|
2002-07-16 |
2004-02-02 |
Elan Pharma International, Ltd |
Liquid dosage compositions of stable nanoparticulate active agents
|
|
US20040045546A1
(en)
*
|
2002-09-05 |
2004-03-11 |
Peirce Management, Llc |
Pharmaceutical delivery system for oral inhalation through nebulization consisting of inert substrate impregnated with substance (S) to be solubilized or suspended prior to use
|
|
EP1556091A1
(en)
*
|
2002-10-04 |
2005-07-27 |
Elan Pharma International Limited |
Gamma irradiation of solid nanoparticulate active agents
|
|
IL152486A0
(en)
|
2002-10-25 |
2003-05-29 |
Meir Eini |
Alcohol-free cosmetic and pharmaceutical foam carrier
|
|
JP2006505583A
(ja)
|
2002-10-25 |
2006-02-16 |
フォーミックス エルティーディー． |
化粧剤および医薬用フォーム
|
|
US8486376B2
(en)
|
2002-10-25 |
2013-07-16 |
Foamix Ltd. |
Moisturizing foam containing lanolin
|
|
US8119109B2
(en)
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Foamable compositions, kits and methods for hyperhidrosis
|
|
US8900554B2
(en)
|
2002-10-25 |
2014-12-02 |
Foamix Pharmaceuticals Ltd. |
Foamable composition and uses thereof
|
|
US7820145B2
(en)
|
2003-08-04 |
2010-10-26 |
Foamix Ltd. |
Oleaginous pharmaceutical and cosmetic foam
|
|
US10117812B2
(en)
|
2002-10-25 |
2018-11-06 |
Foamix Pharmaceuticals Ltd. |
Foamable composition combining a polar solvent and a hydrophobic carrier
|
|
US8119150B2
(en)
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Non-flammable insecticide composition and uses thereof
|
|
US9668972B2
(en)
|
2002-10-25 |
2017-06-06 |
Foamix Pharmaceuticals Ltd. |
Nonsteroidal immunomodulating kit and composition and uses thereof
|
|
US7700076B2
(en)
|
2002-10-25 |
2010-04-20 |
Foamix, Ltd. |
Penetrating pharmaceutical foam
|
|
US20080138296A1
(en)
|
2002-10-25 |
2008-06-12 |
Foamix Ltd. |
Foam prepared from nanoemulsions and uses
|
|
US9265725B2
(en)
|
2002-10-25 |
2016-02-23 |
Foamix Pharmaceuticals Ltd. |
Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
|
|
US7704518B2
(en)
|
2003-08-04 |
2010-04-27 |
Foamix, Ltd. |
Foamable vehicle and pharmaceutical compositions thereof
|
|
US9211259B2
(en)
|
2002-11-29 |
2015-12-15 |
Foamix Pharmaceuticals Ltd. |
Antibiotic kit and composition and uses thereof
|
|
US7550133B2
(en)
|
2002-11-26 |
2009-06-23 |
Alexza Pharmaceuticals, Inc. |
Respiratory drug condensation aerosols and methods of making and using them
|
|
US20040208833A1
(en)
*
|
2003-02-04 |
2004-10-21 |
Elan Pharma International Ltd. |
Novel fluticasone formulations
|
|
JP4707937B2
(ja)
*
|
2003-02-28 |
2011-06-22 |
ホソカワミクロン株式会社 |
薬物含有複合粒子の製造方法および経肺製剤
|
|
US7811606B2
(en)
*
|
2003-04-16 |
2010-10-12 |
Dey, L.P. |
Nasal pharmaceutical formulations and methods of using the same
|
|
US8912174B2
(en)
|
2003-04-16 |
2014-12-16 |
Mylan Pharmaceuticals Inc. |
Formulations and methods for treating rhinosinusitis
|
|
US9808471B2
(en)
|
2003-04-16 |
2017-11-07 |
Mylan Specialty Lp |
Nasal pharmaceutical formulations and methods of using the same
|
|
US7575739B2
(en)
|
2003-04-28 |
2009-08-18 |
Foamix Ltd. |
Foamable iodine composition
|
|
US20040234914A1
(en)
|
2003-05-21 |
2004-11-25 |
Alexza Molecular Delivery Corporation |
Percussively ignited or electrically ingnited self-contained heating unit and drug-supply unit employing same
|
|
EP1626742A1
(en)
*
|
2003-05-22 |
2006-02-22 |
Elan Pharma International Limited |
Sterilization of dispersions of nanoparticulate active agents with gamma radiation
|
|
US7459146B2
(en)
*
|
2003-05-30 |
2008-12-02 |
3M Innovative Properties Company |
Stabilized aerosol dispersions
|
|
US7109247B2
(en)
*
|
2003-05-30 |
2006-09-19 |
3M Innovative Properties Company |
Stabilized particle dispersions containing nanoparticles
|
|
US20040242729A1
(en)
*
|
2003-05-30 |
2004-12-02 |
3M Innovative Properties Company |
Stabilized particle dispersions containing surface-modified inorganic nanoparticles
|
|
DE10325989A1
(de)
*
|
2003-06-07 |
2005-01-05 |
Glatt Gmbh |
Verfahren zur Herstellung von und daraus resultierende Mikropellets sowie deren Verwendung
|
|
JPWO2004110405A1
(ja)
*
|
2003-06-11 |
2006-08-17 |
株式会社奈良機械製作所 |
薬物ナノ粒子、その粒子を使用した薬剤の製造方法および薬剤の製造装置
|
|
WO2004112799A1
(en)
*
|
2003-06-13 |
2004-12-29 |
Chrysalis Technologies Incorporated |
Methods and apparatus for producing nanoscale particles
|
|
US8795693B2
(en)
|
2003-08-04 |
2014-08-05 |
Foamix Ltd. |
Compositions with modulating agents
|
|
US8486374B2
(en)
|
2003-08-04 |
2013-07-16 |
Foamix Ltd. |
Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
|
|
WO2005025535A2
(en)
*
|
2003-09-15 |
2005-03-24 |
Vectura Limited |
Methods for preparing pharmaceutical compositions
|
|
GB0327723D0
(en)
*
|
2003-09-15 |
2003-12-31 |
Vectura Ltd |
Pharmaceutical compositions
|
|
US20060263350A1
(en)
*
|
2003-09-26 |
2006-11-23 |
Fairfield Clinical Trials Llc |
Combination antihistamine medication
|
|
GB0323684D0
(en)
|
2003-10-09 |
2003-11-12 |
Jagotec Ag |
Improvements in or relating to organic compounds
|
|
US20050287077A1
(en)
*
|
2004-02-10 |
2005-12-29 |
James E. Shipley |
Process for preparing stable SOL of pharmaceutical ingredients and hydrofluorocarbon
|
|
US20070053845A1
(en)
*
|
2004-03-02 |
2007-03-08 |
Shiladitya Sengupta |
Nanocell drug delivery system
|
|
EP1722762A2
(en)
*
|
2004-03-02 |
2006-11-22 |
Massachusetts Institute of Technology |
Nanocell drug delivery system
|
|
US20050265928A1
(en)
*
|
2004-05-07 |
2005-12-01 |
President And Fellows Of Harvard College Massachusetts |
Pulmonary malarial vaccine
|
|
US7540286B2
(en)
|
2004-06-03 |
2009-06-02 |
Alexza Pharmaceuticals, Inc. |
Multiple dose condensation aerosol devices and methods of forming condensation aerosols
|
|
US20060009435A1
(en)
*
|
2004-06-23 |
2006-01-12 |
Joseph Kaspi |
Synthesis and powder preparation of fluticasone propionate
|
|
EP1781360A1
(en)
|
2004-08-12 |
2007-05-09 |
Alexza Pharmaceuticals, Inc. |
Aerosol drug delivery device incorporating percussively activated heat packages
|
|
GB0418791D0
(en)
*
|
2004-08-23 |
2004-09-22 |
Glaxo Group Ltd |
Novel process
|
|
EP1789018A1
(en)
|
2004-08-27 |
2007-05-30 |
The Dow Chemical Company |
Enhanced delivery of drug compositions to treat life threatening infections
|
|
US20060073173A1
(en)
*
|
2004-10-04 |
2006-04-06 |
Maria Banach |
Large-scale manufacturing process for the production of pharmaceutical compositions
|
|
BRPI0517374A
(pt)
|
2004-10-29 |
2008-10-07 |
Harvard College |
formulação para tratamento ou prevenção de infecção respiratória, método para tratamento
|
|
WO2007001448A2
(en)
|
2004-11-04 |
2007-01-04 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
|
EA200701065A1
(ru)
*
|
2004-11-16 |
2007-12-28 |
Элан Фарма Интернэшнл Лтд. |
Инъецируемые составы, содержащие нанодисперсный оланзапин
|
|
GB0425758D0
(en)
|
2004-11-23 |
2004-12-22 |
Vectura Ltd |
Preparation of pharmaceutical compositions
|
|
GB0426301D0
(en)
*
|
2004-11-30 |
2004-12-29 |
Vectura Ltd |
Pharmaceutical formulations
|
|
UA89513C2
(uk)
*
|
2004-12-03 |
2010-02-10 |
Элан Фарма Интернешнл Лтд. |
Стабільна композиція з наночастинок ралоксифену гідрохлориду
|
|
KR20070116581A
(ko)
*
|
2004-12-15 |
2007-12-10 |
엘란 파마 인터내셔널 리미티드 |
나노입자형 타크롤리무스 제제
|
|
US20060159767A1
(en)
*
|
2004-12-22 |
2006-07-20 |
Elan Pharma International Limited |
Nanoparticulate bicalutamide formulations
|
|
EA200701442A1
(ru)
*
|
2005-01-06 |
2008-02-28 |
Элан Фарма Интернэшнл Лтд. |
Композиции наночастиц кандесартана
|
|
MX2007009915A
(es)
*
|
2005-02-15 |
2007-11-06 |
Elan Pharma Int Ltd |
Formulaciones en aerosol e inyectables de benzodiazepina nanoparticulada.
|
|
US20060204588A1
(en)
*
|
2005-03-10 |
2006-09-14 |
Elan Pharma International Limited |
Formulations of a nanoparticulate finasteride, dutasteride or tamsulosin hydrochloride, and mixtures thereof
|
|
EP1861072A2
(en)
*
|
2005-03-14 |
2007-12-05 |
Massachusetts Institute Of Technology |
Nanocells for diagnosis and treatment of diseases and disorders
|
|
EA200701987A1
(ru)
*
|
2005-03-16 |
2008-02-28 |
Элан Фарма Интернэшнл Лтд. |
Составы из нанодисперсного антагониста лейкотриеновых рецепторов/кортикостероида
|
|
EP1865928A1
(en)
*
|
2005-03-17 |
2007-12-19 |
Elan Pharma International Limited |
Nanoparticulate biphosphonate compositions
|
|
WO2006102494A2
(en)
*
|
2005-03-23 |
2006-09-28 |
Elan Pharma International Limited |
Nanoparticulate corticosteroid and antihistamine formulations
|
|
JP2008535924A
(ja)
*
|
2005-04-12 |
2008-09-04 |
エラン ファーマ インターナショナル リミテッド |
ナノ粒子キナゾリン誘導体製剤
|
|
WO2006110809A2
(en)
*
|
2005-04-12 |
2006-10-19 |
Elan Pharma International, Limited |
Nanoparticulate lipase inhibitor formulations
|
|
US20090081297A1
(en)
*
|
2005-04-27 |
2009-03-26 |
Cook Robert O |
Use of surface tension reducing agents in aerosol formulations
|
|
EP1954253A4
(en)
|
2005-06-08 |
2011-07-27 |
Elan Pharma Int Ltd |
NANOTEILIC AND CONTROLLED RELEASED COMPOSITIONS WITH CEFDITORS
|
|
US7947308B2
(en)
*
|
2005-07-20 |
2011-05-24 |
Raimar Loebenberg |
Effervescent powders for inhalation
|
|
JP2007079857A
(ja)
*
|
2005-09-13 |
2007-03-29 |
Canon Inc |
サーバー装置、クライアント装置及びそれらの制御方法、コンピュータプログラム、記憶媒体
|
|
EP1933814A2
(en)
|
2005-09-15 |
2008-06-25 |
Elan Pharma International Limited |
Nanoparticulate aripiprazole formulations
|
|
WO2007053923A2
(en)
*
|
2005-11-11 |
2007-05-18 |
Biolab Sanus Farmacêutica Ltda. |
Solid pharmaceutical composition comprising agglomerate nanoparticles and a process for producing the same
|
|
US9267937B2
(en)
|
2005-12-15 |
2016-02-23 |
Massachusetts Institute Of Technology |
System for screening particles
|
|
CN101370479A
(zh)
*
|
2005-12-16 |
2009-02-18 |
堪萨斯州立大学 |
用于递送治疗剂的纳米团簇
|
|
EP1798504A1
(en)
*
|
2005-12-19 |
2007-06-20 |
Koninklijke Philips Electronics N.V. |
Method of making dried particles
|
|
US20070178051A1
(en)
*
|
2006-01-27 |
2007-08-02 |
Elan Pharma International, Ltd. |
Sterilized nanoparticulate glucocorticosteroid formulations
|
|
US20070202182A1
(en)
*
|
2006-02-26 |
2007-08-30 |
Kane Kevin M |
Preparing solid formulation of nanoparticles of pharmaceutical ingredient, including at least micron-sized particles
|
|
US8367112B2
(en)
*
|
2006-02-28 |
2013-02-05 |
Alkermes Pharma Ireland Limited |
Nanoparticulate carverdilol formulations
|
|
FI20060428A7
(fi)
*
|
2006-05-03 |
2007-11-04 |
Esko Kauppinen |
Pintamodifioidut aerosolihiukkaset, menetelmä ja laite niiden tuottamiseksi sekä jauheet ja dispersiot jotka sisältävät kyseisiä hiukkasia
|
|
US8367113B2
(en)
|
2006-05-15 |
2013-02-05 |
Massachusetts Institute Of Technology |
Polymers for functional particles
|
|
US9381477B2
(en)
|
2006-06-23 |
2016-07-05 |
Massachusetts Institute Of Technology |
Microfluidic synthesis of organic nanoparticles
|
|
IN2014MN00380A
(enExample)
|
2006-06-30 |
2015-06-19 |
Iceutica Pty Ltd |
|
|
US20080260655A1
(en)
|
2006-11-14 |
2008-10-23 |
Dov Tamarkin |
Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
|
|
US9044391B2
(en)
*
|
2007-01-10 |
2015-06-02 |
Board Of Regents, The University Of Texas System |
Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery
|
|
US9217129B2
(en)
|
2007-02-09 |
2015-12-22 |
Massachusetts Institute Of Technology |
Oscillating cell culture bioreactor
|
|
JP2008222567A
(ja)
*
|
2007-03-08 |
2008-09-25 |
Iwate Univ |
微粒子の製造方法
|
|
EP2121088B1
(en)
|
2007-03-09 |
2016-07-13 |
Alexza Pharmaceuticals, Inc. |
Heating unit for use in a drug delivery device
|
|
JP2010523595A
(ja)
|
2007-04-04 |
2010-07-15 |
マサチューセッツ インスティテュート オブ テクノロジー |
ポリ（アミノ酸）ターゲッティング部分
|
|
EP3398611B1
(en)
*
|
2007-04-18 |
2020-08-12 |
Particle Sciences, Inc. |
Aerosol dispersions of particles with active pharmaceutical ingredients
|
|
CA2686756A1
(en)
*
|
2007-05-11 |
2008-11-20 |
F. Hoffmann-La Roche Ag |
Pharmaceutical compositions for poorly soluble drugs
|
|
GB0712454D0
(en)
*
|
2007-06-27 |
2007-08-08 |
Generics Uk Ltd |
Pharmaceutical compositions
|
|
US8636982B2
(en)
|
2007-08-07 |
2014-01-28 |
Foamix Ltd. |
Wax foamable vehicle and pharmaceutical compositions thereof
|
|
WO2009020434A1
(en)
*
|
2007-08-07 |
2009-02-12 |
Nanomaterials Technology Pte Ltd |
A process for making micro-sized protein particles
|
|
AU2008310734B2
(en)
|
2007-10-10 |
2014-06-05 |
Parion Sciences, Inc. |
Delivering osmolytes by nasal cannula
|
|
WO2009049304A1
(en)
*
|
2007-10-12 |
2009-04-16 |
Map Pharmaceuticals, Inc. |
Inhalation drug delivery
|
|
CA2917512C
(en)
|
2007-10-12 |
2025-08-05 |
President And Fellows Of Harvard College |
VACCINE NANOTECHNOLOGY
|
|
WO2009069006A2
(en)
|
2007-11-30 |
2009-06-04 |
Foamix Ltd. |
Foam containing benzoyl peroxide
|
|
WO2009073843A1
(en)
*
|
2007-12-06 |
2009-06-11 |
Cytotech Labs, Llc |
Inhalable compositions having enhanced bioavailability
|
|
WO2010041141A2
(en)
|
2008-10-07 |
2010-04-15 |
Foamix Ltd. |
Oil-based foamable carriers and formulations
|
|
WO2009090495A2
(en)
|
2007-12-07 |
2009-07-23 |
Foamix Ltd. |
Oil and liquid silicone foamable carriers and formulations
|
|
US20090238867A1
(en)
*
|
2007-12-13 |
2009-09-24 |
Scott Jenkins |
Nanoparticulate Anidulafungin Compositions and Methods for Making the Same
|
|
WO2009079078A1
(en)
|
2007-12-14 |
2009-06-25 |
Labogroup S.A.S. |
Delivering aerosolizable food products
|
|
AU2009205314A1
(en)
|
2008-01-14 |
2009-07-23 |
Foamix Ltd. |
Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
|
|
EP2095816A1
(en)
*
|
2008-02-29 |
2009-09-02 |
Schlichthaar, Rainer, Dr. |
Nanosuspension with antifungal medication to be administered via inhalation with improved impurity profile and safety
|
|
WO2009117410A2
(en)
*
|
2008-03-17 |
2009-09-24 |
Board Of Regents, The University Of Texas System |
Formation of nanostructured particles of poorly water soluble drugs and recovery by mechanical techniques
|
|
WO2009158300A1
(en)
*
|
2008-06-26 |
2009-12-30 |
3M Innovative Properties Company |
Dry powder pharmaceutical compositions for pulmonary administration, and methods of manufacturing thereof
|
|
US8343498B2
(en)
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
|
US8343497B2
(en)
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
|
WO2010052575A2
(en)
*
|
2008-11-10 |
2010-05-14 |
Scandivir Ab |
Ngna compositions and methods of use
|
|
KR20100052262A
(ko)
*
|
2008-11-10 |
2010-05-19 |
(주)아모레퍼시픽 |
난용성 약물의 나노입자를 포함하는 분말의 제조방법, 그에의해 제조된 분말 및 이를 포함하는 약학적 조성물
|
|
US9028878B2
(en)
|
2009-02-03 |
2015-05-12 |
Microbion Corporation |
Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses
|
|
AU2010210620B2
(en)
|
2009-02-03 |
2016-02-25 |
Microbion Corporation |
Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
|
|
ES2739352T3
(es)
|
2009-02-26 |
2020-01-30 |
Glaxo Group Ltd |
Formulaciones farmacéuticas que comprenden 4-{(1R)-2-[(6-{2-[(2,6-diclorobencil)oxi]etoxi}hexil)amino]-1-hidroxietil}-2-(hidroximetil)fenol
|
|
WO2010102066A1
(en)
|
2009-03-05 |
2010-09-10 |
Bend Research, Inc. |
Dextran polymer powder for inhalation administration of pharmaceuticals
|
|
UA106231C2
(uk)
|
2009-04-24 |
2014-08-11 |
Айсьютика Пти Лтд |
Разова доза фармацевтичної композиції індометацину (варіанти)
|
|
CN102458380A
(zh)
*
|
2009-04-24 |
2012-05-16 |
先灵公司 |
包含具有目的颗粒大小的活性药物试剂的团聚体制剂
|
|
WO2010125470A2
(en)
|
2009-04-28 |
2010-11-04 |
Foamix Ltd. |
Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
|
|
WO2010138193A2
(en)
|
2009-05-27 |
2010-12-02 |
Selecta Biosciences, Inc. |
Targeted synthetic nanocarriers with ph sensitive release of immunomodulatory agents
|
|
CA2763456C
(en)
|
2009-05-27 |
2017-10-24 |
Alkermes Pharma Ireland Limited |
Reduction of flake-like aggregation in nanoparticulate active agent compositions
|
|
US20100310660A1
(en)
*
|
2009-06-08 |
2010-12-09 |
Taipei Medical University |
Dry powder microparticles for pulmonary delivery
|
|
WO2011013008A2
(en)
|
2009-07-29 |
2011-02-03 |
Foamix Ltd. |
Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
|
|
CA2769625C
(en)
|
2009-07-29 |
2017-04-11 |
Foamix Ltd. |
Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
|
|
US20110033545A1
(en)
*
|
2009-08-06 |
2011-02-10 |
Absize, Inc. |
Topical pharmaceutical preparations having both a nanoparticle solution and a nanoparticle suspension and methods for the treatment of acute and chronic pain therewith
|
|
US9849142B2
(en)
|
2009-10-02 |
2017-12-26 |
Foamix Pharmaceuticals Ltd. |
Methods for accelerated return of skin integrity and for the treatment of impetigo
|
|
US8945516B2
(en)
|
2009-10-02 |
2015-02-03 |
Foamix Pharmaceuticals Ltd. |
Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
|
|
GB0918149D0
(en)
|
2009-10-16 |
2009-12-02 |
Jagotec Ag |
Improved medicinal aerosol formulation
|
|
US8174881B2
(en)
|
2009-11-24 |
2012-05-08 |
Micron Technology, Inc. |
Techniques for reducing disturbance in a semiconductor device
|
|
GB0921075D0
(en)
|
2009-12-01 |
2010-01-13 |
Glaxo Group Ltd |
Novel combination of the therapeutic agents
|
|
GB201001070D0
(en)
|
2010-01-22 |
2010-03-10 |
St George's Hospital Medical School |
Theraputic compounds and their use
|
|
ES2664793T3
(es)
|
2010-03-12 |
2018-04-23 |
Berg Llc |
Formulaciones intravenosas de coenzima Q10 (CoQ10) y métodos de uso de las mismas
|
|
WO2011133980A1
(en)
|
2010-04-23 |
2011-10-27 |
Subhash Desai |
Therapeutic formulation for reduced drug side effects
|
|
US9511037B2
(en)
*
|
2010-04-23 |
2016-12-06 |
Genco Sciences Llc |
Compositions for reduction of side effects
|
|
US9012511B2
(en)
|
2010-05-19 |
2015-04-21 |
Alkermes Pharma Ireland Limited |
Nanoparticulate cinacalcet compositions
|
|
WO2011150264A2
(en)
|
2010-05-26 |
2011-12-01 |
Selecta Biosciences, Inc. |
Synthetic nanocarrier combination vaccines
|
|
GB201011411D0
(en)
|
2010-07-06 |
2010-08-18 |
St Georges Hosp Medical School |
Therapeutic compounds and their use
|
|
US8815294B2
(en)
|
2010-09-03 |
2014-08-26 |
Bend Research, Inc. |
Pharmaceutical compositions of dextran polymer derivatives and a carrier material
|
|
US8574630B2
(en)
|
2010-09-22 |
2013-11-05 |
Map Pharmaceuticals, Inc. |
Corticosteroid particles and method of production
|
|
JP2014504260A
(ja)
*
|
2010-10-15 |
2014-02-20 |
グラクソ グループ リミテッド |
集合ナノ粒子状薬物製剤、その製造及び使用
|
|
JOP20120023B1
(ar)
|
2011-02-04 |
2022-03-14 |
Novartis Ag |
صياغات مساحيق جافة من جسيمات تحتوي على واحد أو اثنين من المواد الفعالة لعلاج امراض ممرات الهواء الانسدادية او الالتهابية
|
|
GB201102237D0
(en)
*
|
2011-02-09 |
2011-03-23 |
Kuecept Ltd |
Particle formulation
|
|
EP2675434A1
(en)
|
2011-02-17 |
2013-12-25 |
F.Hoffmann-La Roche Ag |
A process for controlled crystallization of an active pharmaceutical ingredient from supercooled liquid state by hot melt extrusion
|
|
US9084727B2
(en)
|
2011-05-10 |
2015-07-21 |
Bend Research, Inc. |
Methods and compositions for maintaining active agents in intra-articular spaces
|
|
JO3410B1
(ar)
*
|
2011-06-07 |
2019-10-20 |
Otsuka Pharma Co Ltd |
تركيبة أريبيبرازول مجفف بالتبريد
|
|
CN103732213A
(zh)
|
2011-06-07 |
2014-04-16 |
帕里昂科学公司 |
治疗方法
|
|
US8945605B2
(en)
*
|
2011-06-07 |
2015-02-03 |
Parion Sciences, Inc. |
Aerosol delivery systems, compositions and methods
|
|
MX351781B
(es)
|
2011-06-17 |
2017-10-30 |
Berg Llc |
Composiciones farmaceuticas inhalables.
|
|
CA2843274A1
(en)
|
2011-07-29 |
2013-02-07 |
Selecta Biosciences, Inc. |
Synthetic nanocarriers that generate humoral and cytotoxic t lymphocyte (ctl) immune responses
|
|
EP2601973A1
(en)
|
2011-12-09 |
2013-06-12 |
Laboratoires SMB SA |
Dry powder formulation of azole derivative for inhalation
|
|
AU2013221302B2
(en)
*
|
2012-02-16 |
2017-11-23 |
Capnia, Inc. |
Gas dispenser with diffusing nosepiece
|
|
CA2869849A1
(en)
*
|
2012-04-13 |
2013-10-17 |
Glaxosmithkline Intellectual Property Development Limited |
Aggregate particles comprising nanoparticulate drug particles of umeclidinium bromide, vilanterol trifenatate and fluticasone furoate
|
|
CN105102342A
(zh)
*
|
2012-11-01 |
2015-11-25 |
精密阀门有限公司 |
自由流动的气雾剂阀
|
|
US9757529B2
(en)
|
2012-12-20 |
2017-09-12 |
Otitopic Inc. |
Dry powder inhaler and methods of use
|
|
US9757395B2
(en)
|
2012-12-20 |
2017-09-12 |
Otitopic Inc. |
Dry powder inhaler and methods of use
|
|
GB201307659D0
(en)
*
|
2013-04-26 |
2013-06-12 |
Korea Coast Guard Commissioner |
Preparation of drug particles by micronisation
|
|
AU2013388034B2
(en)
|
2013-04-30 |
2019-08-15 |
Aspeya US Inc. |
Dry powder formulations and methods of use
|
|
EP3082428A4
(en)
|
2013-12-09 |
2017-08-02 |
Respira Therapeutics, Inc. |
Pde5 inhibitor powder formulations and methods relating thereto
|
|
CA2977083A1
(en)
|
2014-02-20 |
2015-08-27 |
Kambiz Yadidi |
Dry powder formulations for inhalation
|
|
US9526734B2
(en)
|
2014-06-09 |
2016-12-27 |
Iceutica Pty Ltd. |
Formulation of meloxicam
|
|
US10751319B2
(en)
|
2015-06-04 |
2020-08-25 |
Crititech, Inc. |
Collection device and methods for use
|
|
EP3439635B1
(en)
|
2016-04-04 |
2020-12-09 |
Crititech, Inc. |
Formulations for solid tumor treatment
|
|
GB201609925D0
(en)
*
|
2016-06-07 |
2016-07-20 |
Novabiotics Ltd |
Formulation
|
|
MX377365B
(es)
|
2016-09-08 |
2025-03-10 |
Journey Medical Corp |
Composiciones y métodos para tratar rosácea y acné.
|
|
SG10201913649TA
(en)
|
2017-06-09 |
2020-03-30 |
Crititech Inc |
Treatment of epithelial cysts by intracystic injection of antineoplastic particles
|
|
KR102303762B1
(ko)
|
2017-06-14 |
2021-09-23 |
크리티테크, 인크. |
폐 장애의 치료 방법
|
|
BR112020005814A2
(pt)
|
2017-10-03 |
2020-09-24 |
Crititech, Inc. |
administração local de partículas antineoplásicas em combinação com administração sistêmica de agentes imunoterapêuticos para o tratamento de câncer
|
|
US11534397B2
(en)
*
|
2017-11-09 |
2022-12-27 |
The Board Of Regents Of The University Of Oklahoma |
Nanocrystal microparticles of poorly soluble drugs and methods of production and use thereof
|
|
WO2019126703A1
(en)
|
2017-12-22 |
2019-06-27 |
Ecolab Usa Inc. |
Antimicrobial compositions with enhanced efficacy
|
|
MX2020007997A
(es)
|
2018-02-02 |
2020-12-03 |
Alexza Pharmaceuticals Inc |
Dispositivo electrico de aerosol de condensacion.
|
|
CN108651937B
(zh)
*
|
2018-04-20 |
2021-12-24 |
大连工业大学 |
一种基于超声波喷雾冷冻干燥生产高汤调味粉的方法
|
|
JP2021522308A
(ja)
|
2018-05-04 |
2021-08-30 |
トゥリーズ |
上皮細胞及び骨髄細胞の両方を活性化するｔｌｒ３リガンド
|
|
EA202190331A1
(ru)
*
|
2018-07-24 |
2021-06-17 |
Борд Оф Риджентс, Дзе Юниверсити Оф Техас Систем |
Композиции терапевтически активных частиц с модифицированной поверхностью, полученные путем ультрабыстрой заморозки
|
|
CA3107760A1
(en)
*
|
2018-07-31 |
2020-02-06 |
Microbion Corporation |
Bismuth-thiol compositions and methods of use
|
|
EP3829299A4
(en)
|
2018-07-31 |
2022-04-13 |
Microbion Corporation |
BISMUTH THIOL COMPOSITIONS AND METHODS OF TREATMENT OF WOUNDS
|
|
WO2022189861A1
(en)
|
2021-03-08 |
2022-09-15 |
Tollys |
Carbohydrate conjugates of tlr3 ligands and uses thereof
|
|
WO2023112966A1
(ja)
*
|
2021-12-14 |
2023-06-22 |
ダイキン工業株式会社 |
噴霧装置、および空気処理装置
|
|
MX2024010565A
(es)
|
2022-03-02 |
2024-09-06 |
Horizon Therapeutics Ireland Dac |
Procedimiento de fabricacion de un antagonista cristalino del receptor edg-2.
|